Administering a Pyr10 inhibitor to block TRPC3 channel alleviated the development of LPS-induced sepsis in mice by reducing the activation of several pro-inflammatory genes, including PTGS2, TNFA, IL-1B, and IL-6 [107]. Here, TRPC3 is linked to Sepsis.